Living Kidney Donor clinical trials at UCSF
1 research study open to new patients
-
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
open to eligible people ages 18 years and up
The purpose of this study is: - To see if polyTregs and/or "donor reactive" darTregs can reduce inflammation in a transplanted kidney. - To find out what effects, good or bad, polyTregs or darTregs will have in the kidney recipient. - To find out what effects, good or bad, taking everolimus after polyTregs or darTregs will have in the kidney recipient.
San Francisco, California and other locations
Last updated: